| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |